Weight gain, fat formation, bone mineral content decreased, white adipose tissue weight gain, cholesterol levels rise, leptin levels rise, insulin resistance, II diabetes, elevated blood glucose levels, inflammatory disease, osteoarthritis, the present invention, high blood pressure (accumulation of fat in the liver) fatty liver disease cardiovascular disease, such as stroke or blood pressure increased, non-alcoholic steatohepatitis, such as (NASH), (UCP-1) values decrease, lipogenesis and uncoupling protein-1 to a method of preventing and / or treating metabolic disorders, including increasing, a disease associated with high-fat diet and postmenopausal obesity. None [selection Figure FIG.本発明は、体重増加、脂肪形成、骨無機質含量低下、白色脂肪組織重量増加、コレステロール値上昇、レプチン値上昇、インスリン耐性、II型糖尿病、血糖値上昇、炎症性疾患、変形性関節症、高血圧、血圧亢進または脳卒中等の心臓血管疾患、非アルコール性脂肪性肝炎(NASH)などの脂肪肝疾患(肝臓への脂肪の蓄積)、脱共役タンパク質-1(UCP-1)値低下、および脂質生成増加を含む代謝障害、閉経後肥満および高脂肪食摂取に関連する疾患を予防および/または治療する方法に関する。【選択図】図なし
